ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 746513 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 746513; 2) Community: the network communities that were significantly associated with the response to NSC 746513; 3) Molecule: the relationships between components within communities and NSC 746513; 4) MDR: the compounds that were significantly associated with the NSC 746513.

NSC Compound Enrichment Correlation
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0396077140933377 0.068800657
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0396077140933377 0.28165119
NSC 47468 Null 0.0396077140933377 0.26863357
NSC 603071 Aminocamptothecin 0.0396077140933377 0.17023902
NSC 606497 Camptothecin Derivative 0.0396077140933377 0.15176963
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0396077140933377 0.384471
NSC 626162 Discorhabdin C . TFA 0.0396077140933377 0.40011845
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0396077140933377 0.3081163
NSC 63878 Cytarabine Hydrochloride AZ 0.0396077140933377 0.12464787
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0396077140933377 0.43174239
Total:74  Current:62    [First] [Prev] [Next] [Last]